Inovio Pharmaceuticals (INO) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $2.0 million.
- Inovio Pharmaceuticals' Other Non-Current Assets rose 25530.06% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 25530.06%. This contributed to the annual value of $2.0 million for FY2024, which is 22704.53% up from last year.
- According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Other Non-Current Assets is $2.0 million, which was up 25530.06% from $2.0 million recorded in Q2 2025.
- In the past 5 years, Inovio Pharmaceuticals' Other Non-Current Assets ranged from a high of $25.9 million in Q1 2021 and a low of $566415.0 during Q3 2024
- Its 5-year average for Other Non-Current Assets is $2.5 million, with a median of $770144.0 in 2022.
- Per our database at Business Quant, Inovio Pharmaceuticals' Other Non-Current Assets surged by 94358.98% in 2021 and then tumbled by 9507.84% in 2022.
- Quarter analysis of 5 years shows Inovio Pharmaceuticals' Other Non-Current Assets stood at $1.4 million in 2021, then crashed by 52.02% to $684044.0 in 2022, then decreased by 11.51% to $605315.0 in 2023, then surged by 227.05% to $2.0 million in 2024, then rose by 1.66% to $2.0 million in 2025.
- Its Other Non-Current Assets stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.